Nucleus was the original Sonata client who drove all the UK growth. Them moving to FNZ is a clear indication that BVS have not invested sufficiently into R&D. This is always the risk with a fintech that pays dividends. They serve two masters which rarely ends well.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.27 |
Change
0.050(2.25%) |
Mkt cap ! $1.017B | |||
| Open | High | Low | Value | Volume |
| $2.21 | $2.27 | $2.20 | $540.4K | 240.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3834 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 15800 | 9 |
View Market Depth
| Last trade - 11.29am 27/06/2025 (20 minute delay) ? |
| BVS (ASX) Chart |